Understanding Managerial Transactions at Genmab A/S
Company Announcement
COPENHAGEN, Denmark; An important update from Genmab A/S (Nasdaq: GMAB) informs us about transactions made by its managerial employees and their closely associated persons. This disclosure follows the regulations outlined in Article 19 of Regulation No. 596/2014.
Genmab places a high priority on transparency, empowering its managerial employees and their associates to allow the company to make their trading activities public. This decision emphasizes Genmab’s commitment to ethical practices in corporate governance.
About Genmab A/S
Genmab is an internationally recognized biotechnology firm focused on crafting innovative antibody therapeutics. Thanks to its dedicated team, Genmab has remained at the forefront of biomedical advancements for more than 25 years. Their groundbreaking intellect has led to the creation of sophisticated antibody technology platforms while employing cutting-edge data science for product development.
The company’s pledge is to transform patient care through state-of-the-art antibody medicines by 2030. Their vision, expressed as "knock-your-socks-off (KYSO) antibody medicines,” seeks to deliver life-changing treatments for individuals battling cancer and serious diseases.
Company Highlights
Since its inception in 1999, Genmab A/S has anchored itself in Copenhagen with a significant presence in North America, Europe, and the Asia-Pacific region. This diverse geographical footprint enhances its ability to connect with various stakeholders and facilitates efficient global operations.
By consistently pushing the envelope in antibody treatment solutions, Genmab not only garners recognition but also sets aspiring benchmarks in the biotechnology industry.
Managerial Staff Contacts
For further inquiries, two key representatives at Genmab can be contacted: Marisol Peron, Senior Vice President of Global Communications, and Andrew Carlsen, Vice President focusing on Investor Relations. They are reachable via their direct phone lines and corporate email addresses.
If you're interested in knowing more about Genmab's strategies or product lines, feel free to reach out for the latest updates.
Frequently Asked Questions
What type of transactions are disclosed by Genmab's management?
These transactions include trading activities executed by managerial employees and their closely associated entities, emphasizing transparency.
How does Genmab ensure transparency in its operations?
Genmab empowers its managerial staff to disclose their trading activities to maintain high standards of corporate governance and transparency.
What sectors does Genmab focus on?
Genmab specializes in biotechnology, particularly in developing innovative antibody therapeutics targeting cancer and serious diseases.
How can I stay updated on Genmab's news?
Visit Genmab's official website or follow their social media channels for the latest updates and announcements.
Who should I contact for investor relations inquiries?
For investor relations matters, you can reach Andrew Carlsen at Genmab, who can assist with your queries.
